Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

BACKGROUND: IGF-1 is an essential neurotrophin produced peripherally and in the brain. Impairments in the brain IGF-1 concentrations might be responsible for some aspects of major depressive disorder (MDD) pathogenesis, whereas peripheral IGF-1 could have the marker value. We aimed: 1) to compare se...

Descripción completa

Detalles Bibliográficos
Autores principales: Levada, Oleg A., Troyan, Alexandra S., Pinchuk, Irina Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206727/
https://www.ncbi.nlm.nih.gov/pubmed/32384884
http://dx.doi.org/10.1186/s12888-020-02636-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206727/
https://www.ncbi.nlm.nih.gov/pubmed/32384884
http://dx.doi.org/10.1186/s12888-020-02636-7

Ejemplares similares